Comments on: “Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity”

Olaf van Tellingen; Mark C. de Gooijer; Jann N. Sarkaria; William F. Elmquist

doi:10.1093/neuonc/noaa112

Comments on: “Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity”

Olaf van Tellingen, Mark C. de Gooijer, Jann N. Sarkaria, William F. Elmquist

Pharmaceutics

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1404-1405
Number of pages	2
Journal	Neuro-Oncology
Volume	22
Issue number	9
DOIs	https://doi.org/10.1093/neuonc/noaa112
State	Published - Sep 1 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1093/neuonc/noaa112

OpenUrl availability

Full text

Cite this

@article{a831546a460549fc85530aaa42436fc7,

title = "Comments on: “Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity”",

author = "{van Tellingen}, Olaf and {de Gooijer}, {Mark C.} and Sarkaria, {Jann N.} and Elmquist, {William F.}",

year = "2020",

month = sep,

day = "1",

doi = "10.1093/neuonc/noaa112",

language = "English (US)",

volume = "22",

pages = "1404--1405",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Comments on

T2 - “Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity”

AU - van Tellingen, Olaf

AU - de Gooijer, Mark C.

AU - Sarkaria, Jann N.

AU - Elmquist, William F.

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85092332159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092332159&partnerID=8YFLogxK

U2 - 10.1093/neuonc/noaa112

DO - 10.1093/neuonc/noaa112

M3 - Letter

C2 - 32556220

AN - SCOPUS:85092332159

SN - 1522-8517

VL - 22

SP - 1404

EP - 1405

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - 9

ER -

Comments on: “Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity”

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this